A PCR assay was developed for the diagnosis of invasive aspergillosis in immunocompromised patients. For this purpose, the complete nucleotide sequences of the genes encoding the 18S rRNA of Aspergillus nidulans, Aspergillus terreus, Aspergillus niger, and Aspergillus flavus were elucidated and aligned to the sequences of Aspergillusfumigatus and other clinically relevant prokaryotic and eukaryotic microorganisms. Genus-specific sequences could be identified in the V7 to V9 region of 18S rRNA. By using hot-start PCR, Southern blot hybridization, and restriction enzyme analysis, Aspergillus-specific and -sensitive determination was achieved.
The genus Aspergillus is a ubiquitous saprophytic soil fungus which colonizes the respiratory tract in humans (6) and is responsible for opportunistic infection in immunocompromised patients (18, 21, 25) . Indeed, invasive aspergillosis is responsible for up to 41% of the deaths of patients with acute leukemia, and despite the severity and high mortality attributable to this mycosis, there has been little progress in accurately diagnosing infection antemortem (4, 14) . While isolation of the fungus from sputum and bronchoalveolar lavage (BAL) fluid is indicative of infection, both specimens lack sufficient specificity and sensitivity (9, 15) . Although the invasive techniques necessary to obtain a biopsy are usually precluded because of profound thrombocytopenia, the histological demonstration of fungal elements in tissue is mandatory for proven infection (6) . Serology has little to offer as an alternative since the immune response is desultory and, hitherto, the detection of antigen has met with little success. Since successful treatment depends upon intervening before fungal proliferation becomes overwhelming (1, 8) and since there is, as yet, no rapid reliable means of diagnosis, therapy is begun empirically, often on the most permissive basis such as persistent unexplained fever despite broad-spectrum antibacterial therapy, and continued until after the recovery of granulocytes.
Recent studies have described PCR methods for detecting
Aspergillus fumigatus and Aspergillus flavus in clinical material from immunosuppressed patients (17, 20, 22) . However, other species can be involved (6) , and so it seemed important to us to ascertain that a patient had infection with any Aspergillus organism. We therefore elucidated the complete sequences of 18S rRNA of several species of Aspergillus and related fungi and aligned them with sequences from other sources. In this way, it was possible to develop a sensitive and specific detection assay for the genus Aspergillus which could be validated in cell destruction was achieved by high-frequency shaking at 6,000 vibrations per min for 160 s in a Mini-Beadbeater system (Tecnolab Int., Alkmaar, The Netherlands). Next, the mixture was centrifuged for 15 min at 2,500 rpm (Eppendorf centrifuge). Nucleic acids were purified by successive phenol, phenol-chloroform-isoamyl alcohol (25:24:1), and chloroformisoamyl alcohol extraction (13) followed by precipitation with ethanol overnight at -20°C and were finally dissolved in 100 pl1 of DEPC-treated distilled water which contained 0.4 U of human placental RNase inhibitor per Rl (RNasin; Promega, Leiden, The Netherlands).
The complete 18S rDNA was amplified by PCR using the general eukaryotic 5' and 3' 18S rRNA primers 5'-CCTGGT TGATCCTGCCAGTA-3' and 5'-GCTTGATCCTTCTGCA GGTT-3', respectively (7) . PCR was performed with a 1OO-pIl reaction mixture containing 10 mM Tris-HCl (pH 9 .0 at 25°C), 10 (19) . Annealing of a primer to the template was performed by heat denaturing double-stranded PCR products in the presence of a primer and then immediately freezing them in a C02-cooled ethanol bath. Primers selected from several conserved regions of 18S RNA served as sequencing primers. The resultant sequences were aligned to those of A. fumigatus and the other organisms detailed earlier by a sequence analysis software package (Genetics Computer Group at the University of Wisconsin) implemented on a VAX computer, and Aspergillus genus-specific sequences were selected and tested for specificity. Initially, it appeared impossible to distinguish Aspergillus organisms from the Penicillium and Paecilomyces strains. Consequently, the 18S rRNA genes of these fungi were also sequenced. Subsequent alignment resulted in two primers for the Aspergillus genus-specific PCR assay which yielded a 363-bp fragment for positive amplification: Aspl, 5'-CGGC CCTTAAATAGCCCGGTC-3', located in the V7 region; and Asp2, 5'-ACCCCCCTGAGCCAGTCCG-3', located in the V9 region of the 18S rRNA (see Fig. 1 (13) . Before Southern blotting, the agarose gel was depurinated in 0.25 N HCl, denatured in 0.5 N NaOH-1.5 M NaCl, and transferred to a nylon membrane (Hybond; Amersham Int., Bucks, England) by diffusion blotting in 0.5 N NaOH-1.5 M NaCl. DNA was covalently bound to the membrane by baking at 80°C for 2 h. Membranes were then prehybridized in 6x SSC (lx SSC consists of 15 
RESULTS
Selection of an Aspergillus genus-specific primer set and probe. The sequence alignment data of the V7 to V9 regions of the rRNA of the different Aspergillus species showed extensive homology with those of Penicillium mameffei, Penicillium chrysogenum, and Paecilomyces variotii ( Fig. 1) but not with those of the other microorganisms. One primer which was fully homologous to allAspergillus species but had a single mismatch to Penicillium chrysogenum, Paecilomyces variotii, and Penicillium mameffei (Fig. 1) was selected from the variable region V7. The other primer selected from the variable region V9 was not absolutely conserved for all Aspergillus species and displayed one or two mismatches and dispersed variability. Penicillium mameffei contained only one mismatch while the Paecilomyces isolate was completely homologous (Fig. 1) . Penicillium chrysogenum contained four mismatches, making it unsuitable for hot-start PCR with high-temperature annealing.
The probe finally selected comprised part of the conserved region between the variable regions V7 and V8 and was homologous to theAspergillus isolates and Paecilomyces variotii but not Penicillium mameffei, in which the sequence contained two mismatches. A single base difference in the variable region V8 between theAspergillus species and the other molds yielded an endonuclease Styl site, thereby permitting endonuclease restriction analysis of the amplification products to distinguish theAspergillus species from Paecilomyces variotii (Fig. 1) . Thus, by using a PCR assay that combines amplification, hybridization, and endonuclease restriction analysis, it should be possible to specifically identify Aspergillus species.
Specificity of the Aspergillus genus-specific PCR assay. Hotstart PCR was performed to exclude nonspecific primer annealing. At an annealing temperature of 62°C, specific amplification was observed with all the Aspergillus species and also with Penicillium mameffei and Paecilomyces variotii but with none of the other microorganisms, including Penicillium chrysogenum (Fig. 2) . Southern blot analysis with the internal oligonucleotide probe showed clear hybridization with all the Aspergillus species and Paecilomyces variotii but not with Penicillium mameffei (Fig. 2) . To distinguish Aspergillus spp. from Paecilomyces variotii, 25 [lI of each amplification reaction was digested with StyI ( Fig. 3) (Fig. 4A) . However, when the rRNA was first transcribed into cDNA, 10 fg of nucleic acids was detected on the gel (Fig. 4B) . Southern blot analysis with the Aspergillus oligonucleotide probe increased the sensitivity another 10-fold.
Experimentally infected mice. A. fumigatus was cultured from multiple foci in the lungs of all six infected mice (mice 1 to 6, Table 2) while the PCR was positive for only five animals (Fig. 5 ). Hyphae were also found in the livers, although A. fumigatus was not recovered by culture. PCR on liver tissue was positive in each case, although the amplification signal was less intense than that obtained from the corresponding lungs (Fig. 5) . In mouse 2, there was no histological evidence for invasive aspergillosis in either the lung or liver, and the culture and PCR both proved negative. There was neither histological nor cultural evidence of A. fumigatus in any of the lungs and livers from the healthy, immunosuppressed control mice (mice 7 to 10, (Fig. 6, lanes 4) . Three months later, this patient underwent BAL, having developed a pulmonary infiltrate during another episode of neutropenia. Cultures of BAL fluid were again negative, but PCR remained positive (Fig. 6, lanes 5) . The last patient with proven aspergillosis (patient 4) had initially developed a pulmonary infiltrate 8 months earlier during remission induction therapy. Candida albicans was isolated from the BAL fluid sample, although A samples were positive by PCR (Fig. 6, lanes 2 and 3) . The last patient (patient 9) from whom the BAL fluid sample was PCR positive had developed bilateral pulmonary infiltrates which resolved following neutrophil recovery while completing treatment for acute nonlymphocytic leukemia. All positive samples were confirmed to be Aspergillus specific by StyI restriction endonuclease digestion. Samples from the 5 remaining pa- tients were negative by PCR as were those obtained from 14 nonimmunosuppressed patients.
DISCUSSION
Invasive aspergillosis is one of the major clinical concerns in immunocompromised patients because it is difficult to detect, even in the case of extensive systematic infections, and treatment appears to be successful only when started in an early stage of disease (8) . While prevention of infection remains the ultimate goal, identifying those individuals at greatest risk by a rapid diagnosis would provide an alternative since these are most likely to benefit from early treatment. Recently, several investigators reported the use of PCR to detect A. fumigatus and A. flavus in high-risk patients (17, 20, 22) . However, infection due to other species is not uncommon (11, 25) , and so it seems important to detect all clinically relevant Aspergillus species by developing a genus-specific PCR assay such as we describe.
rRNA has been used as the target for the development of species-or genus-specific PCR assays for several different microorganisms, such as mycobacteria and mycoplasmas (3, 24) . Since only the 18S rRNA of A. fumigatus had been previously sequenced (2) (6) . Additional Southern blot hybridization did not alter the number of patients with positive results, suggesting that no more than 9 of the 14 patients (64%) who developed pulmonary infiltrates during immunosuppression were actually at risk of aspergillosis. Although our tertiary-care 1,000-bed university hospital admits several immunocompromised patients, the study of diseases of low prevalence, like invasive aspergillosis, will inevitably be limited by the small number of patients. The only definitive diagnosis of proven invasive aspergillosis is by histopathological examination of tissues. In most instances, this is only possible postmortem. Antemortem diagnosis is, in our hospital, only possible on BAL fluid and, in most cases, not by open-lung biopsy because of the associated thrombocytopenia. Therefore, most cases will be probable or possible. There is always a possibility of false positivity with this approach. However, PCR results should be interpreted in the whole clinical context of the patient (e.g., a neutropenic or otherwise immunocompromised patient, treatment with broad-spectrum antibiotics, persisting fever, and new infiltrates on chest X ray). We have begun to study a larger group of patients to prospectively determine the value of PCR for the rapid and early diagnosis of invasive aspergillosis. Autopsy surveys have shown that invasive aspergillosis developed in around 45% of the patients who died of hematological malignancy (14, 26) . However, current treatment modalities are not without risk, and even though the practice of early empiric therapy is fairly widespread (10, 16), a better determination of the group of patients at risk remains a desirable goal. This requires a test with maximum sensitivity, and so it seems appropriate to consider any immunosuppressed patient with a BAL fluid sample yielding a positive (Southern blot) PCR result as being at risk of invasive aspergillosis. We recently used interrepeat PCR fingerprinting to demonstrate genotypic heterogenicity among A. fumigatus isolates originating from different patients and different anatomical locations (23) . This assay by which different isolates can be genotypically characterized can be used in the study of the epidemiology of invasive aspergillosis.
In conclusion, the PCR technique we have developed appears suitable to study a large group of patients and to identify those at risk of invasive aspergillosis. One of the main limitations now is that the method itself cannot yet be easily performed in every microbiological laboratory, since trained personnel and experience with PCR are necessary. However, once validated, a method such as ours could have a major impact in reducing the morbidity and mortality of patients undergoing treatment for cancer and hematological malignancy by allowing the early institution of therapy on a more selective basis than is possible at present.
